Assessment on implantable defibrillators and the evidence for primary prevention of sudden cardiac death

Most studies excluded older adults over 70 to 80 years. SCD occurred in 4 to 13 percent of control patients during the 2 to 5 years after randomization. A high strength of evidence shows early (in-hospital) adverse event rates of approximately 3 percent and serious adverse event rates of approximate...

Full description

Bibliographic Details
Main Author: Uhlig, Katrin
Corporate Authors: Tufts Evidence-based Practice Center, Technology Assessment Program (Agency for Healthcare Research and Quality)
Format: eBook
Published: Rockville, Maryland AHRQ, Technology Assessment Program June 26, 2013, 2013
Series:Technology assessment report
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Table of Contents:
  • Includes bibliographical references